当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件19583条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Propafenone hydrochloride
DRUG FOR FURTHER PROCESSING
0591-0583
Actavis Pharma, Inc.
2000/10/24 0:00:00
PROPAFENON
DRUG FOR FURTHER PROCESSING
225
0591-0583_
Labetalol hydrochloride
DRUG FOR FURTHER PROCESSING
0591-0605
Actavis Pharma, Inc.
1998/8/3 0:00:00
LABETALOL
DRUG FOR FURTHER PROCESSING
100
0591-0605_
Labetalol hydrochloride
DRUG FOR FURTHER PROCESSING
0591-0606
Actavis Pharma, Inc.
1998/8/3 0:00:00
LABETALOL
DRUG FOR FURTHER PROCESSING
200
0591-0606_
Labetalol hydrochloride
DRUG FOR FURTHER PROCESSING
0591-0607
Actavis Pharma, Inc.
1998/8/3 0:00:00
LABETALOL
DRUG FOR FURTHER PROCESSING
300
0591-0607_
Nicotine Polacrilex Gum, 2 mg
BULK INGREDIENT
0591-0608
Actavis Pharma, Inc.
2017/9/29 0:00:00
NICOTINE
DRUG FOR FURTHER PROCESSING
2
0591-0608_
Nicotine Polacrilex Gum, 4 mg
BULK INGREDIENT
0591-0609
Actavis Pharma, Inc.
2017/10/9 0:00:00
NICOTINE
DRUG FOR FURTHER PROCESSING
4
0591-0609_
Nicotine Polacrilex Gum, 2 mg
BULK INGREDIENT
0591-0612
Actavis Pharma, Inc.
2017/9/8 0:00:00
NICOTINE
DRUG FOR FURTHER PROCESSING
2
0591-0612_
Nicotine Polacrilex Gum, 4 mg
BULK INGREDIENT
0591-0613
Actavis Pharma, Inc.
2017/8/29 0:00:00
NICOTINE
DRUG FOR FURTHER PROCESSING
4
0591-0613_
Hydroxychloroquine Sulfate
DRUG FOR FURTHER PROCESSING
0591-0698
Actavis Pharma, Inc.
2016/2/3 0:00:00
HYDROXYCHL
DRUG FOR FURTHER PROCESSING
200
0591-0698_
Estazolam
DRUG FOR FURTHER PROCESSING
0591-0744
Actavis Pharma, Inc.
2014/11/19 0:00:00
ESTAZOLAM
DRUG FOR FURTHER PROCESSING
1
0591-0744_
Estazolam
DRUG FOR FURTHER PROCESSING
0591-0745
Actavis Pharma, Inc.
2014/11/19 0:00:00
ESTAZOLAM
DRUG FOR FURTHER PROCESSING
2
0591-0745_
Lisinopril and hydrochlorothiazide
DRUG FOR FURTHER PROCESSING
0591-0860
Actavis Pharma, Inc.
2003/3/1 0:00:00
HYDROCHLOR
DRUG FOR FURTHER PROCESSING
0591-0860_
Lisinopril and hydrochlorothiazide
DRUG FOR FURTHER PROCESSING
0591-0861
Actavis Pharma, Inc.
2003/3/1 0:00:00
HYDROCHLOR
DRUG FOR FURTHER PROCESSING
0591-0861_
Lisinopril and hydrochlorothiazide
DRUG FOR FURTHER PROCESSING
0591-0862
Actavis Pharma, Inc.
2003/3/1 0:00:00
HYDROCHLOR
DRUG FOR FURTHER PROCESSING
0591-0862_
Lisinopril
DRUG FOR FURTHER PROCESSING
0591-0885
Actavis Pharma, Inc.
2002/7/1 0:00:00
LISINOPRIL
DRUG FOR FURTHER PROCESSING
30
0591-0885_
Ramelteon
DRUG FOR FURTHER PROCESSING
0591-2191
Actavis Pharma, Inc.
2019/7/22 0:00:00
RAMELTEON
DRUG FOR FURTHER PROCESSING
8
0591-2191_
Propafenone Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-2285
Actavis Pharma, Inc.
2015/9/22 0:00:00
PROPAFENON
DRUG FOR FURTHER PROCESSING
225
0591-2285_
Propafenone Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-2286
Actavis Pharma, Inc.
2015/9/22 0:00:00
PROPAFENON
DRUG FOR FURTHER PROCESSING
325
0591-2286_
Propafenone Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-2287
Actavis Pharma, Inc.
2015/9/22 0:00:00
PROPAFENON
DRUG FOR FURTHER PROCESSING
425
0591-2287_
Alvimopan
DRUG FOR FURTHER PROCESSING
0591-2312
Actavis Pharma, Inc.
2020/10/13 0:00:00
ALVIMOPAN
DRUG FOR FURTHER PROCESSING
12
0591-2312_
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3